Log on / register
Feedback | Support | My details
The role of the purinergic P2X7 receptor in inflammation.
Lister MF, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K
J Inflamm (Lond) 2007, 4:5
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis.
Yilmaz O, Yao L, Maeda K, Rose TM, Lewis EL, Duman M, Lamont RJ, Ojcius DM
Cell Microbiol 2008 Apr, 10:863-75
 [PubMed Central] [PubMed] [Related articles]
2.
The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.
Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A, Di Virgilio F, Zanetti M
J Biol Chem 2008 Nov 7, 283:30471-81
 [PubMed Central] [PubMed] [Related articles]
3.
Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.
Fu W, McCormick T, Qi X, Luo L, Zhou L, Li X, Wang BC, Gibbons HE, Abdul-Karim FW, Gorodeski GI
BMC Cancer 2009, 9:114
 [PubMed Central] [PubMed] [Related articles]
4.
P2 receptors in renal pathophysiology.
Turner CM, Elliott JI, Tam FW
Purinergic Signal 2009 Dec, 5:513-20
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.